Structure

Physi-Chem Properties

Molecular Weight:  658.19
Volume:  622.098
LogP:  2.639
LogD:  1.398
LogS:  -2.992
# Rotatable Bonds:  11
TPSA:  238.97
# H-Bond Aceptor:  15
# H-Bond Donor:  7
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.113
Synthetic Accessibility Score:  4.959
Fsp3:  0.406
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.446
MDCK Permeability:  4.622393680620007e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.082
Human Intestinal Absorption (HIA):  0.894
20% Bioavailability (F20%):  0.738
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.105
Plasma Protein Binding (PPB):  96.50829315185547%
Volume Distribution (VD):  0.355
Pgp-substrate:  6.9174275398254395%

ADMET: Metabolism

CYP1A2-inhibitor:  0.11
CYP1A2-substrate:  0.019
CYP2C19-inhibitor:  0.125
CYP2C19-substrate:  0.043
CYP2C9-inhibitor:  0.461
CYP2C9-substrate:  0.186
CYP2D6-inhibitor:  0.095
CYP2D6-substrate:  0.121
CYP3A4-inhibitor:  0.181
CYP3A4-substrate:  0.083

ADMET: Excretion

Clearance (CL):  3.977
Half-life (T1/2):  0.966

ADMET: Toxicity

hERG Blockers:  0.199
Human Hepatotoxicity (H-HT):  0.085
Drug-inuced Liver Injury (DILI):  0.935
AMES Toxicity:  0.032
Rat Oral Acute Toxicity:  0.19
Maximum Recommended Daily Dose:  0.052
Skin Sensitization:  0.63
Carcinogencity:  0.688
Eye Corrosion:  0.003
Eye Irritation:  0.068
Respiratory Toxicity:  0.758

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC145847

Natural Product ID:  NPC145847
Common Name*:   2'-O-P-Hydroxybenzoyl-6'-O-Trans-Caffeoyl-8-Epiloganic Acid
IUPAC Name:   (1S,4aS,6S,7S,7aS)-1-[(2S,3R,4S,5S,6R)-6-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-4,5-dihydroxy-3-(4-hydroxybenzoyl)oxyoxan-2-yl]oxy-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylic acid
Synonyms:  
Standard InCHIKey:  LCVJKCLBUJNLAY-ZLTHKTTISA-N
Standard InCHI:  InChI=1S/C32H34O15/c1-14-21(35)11-18-19(29(40)41)12-44-31(25(14)18)47-32-28(46-30(42)16-4-6-17(33)7-5-16)27(39)26(38)23(45-32)13-43-24(37)9-3-15-2-8-20(34)22(36)10-15/h2-10,12,14,18,21,23,25-28,31-36,38-39H,11,13H2,1H3,(H,40,41)/b9-3+/t14-,18-,21+,23-,25-,26-,27+,28-,31+,32+/m1/s1
SMILES:  O=C(/C=C/c1ccc(c(c1)O)O)OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@@H]3[C@H]2[C@H](C)[C@H](C3)O)C(=O)O)[C@@H]([C@H]([C@@H]1O)O)OC(=O)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL508253
PubChem CID:   11365823
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6184 Vitex altissima Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[15620243]
NPO6184 Vitex altissima Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6184 Vitex altissima Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 31900.0 nM PMID[457093]
NPT1 Others Radical scavenging activity IC50 = 11400.0 nM PMID[457093]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC145847 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC109990
0.9739 High Similarity NPC187205
0.9684 High Similarity NPC21956
0.9355 High Similarity NPC475484
0.9299 High Similarity NPC179914
0.9221 High Similarity NPC289021
0.9221 High Similarity NPC158546
0.9125 High Similarity NPC476011
0.9119 High Similarity NPC138993
0.9 High Similarity NPC474936
0.8968 High Similarity NPC478236
0.8968 High Similarity NPC96599
0.8968 High Similarity NPC478234
0.8957 High Similarity NPC130730
0.8957 High Similarity NPC301910
0.891 High Similarity NPC117346
0.891 High Similarity NPC240592
0.891 High Similarity NPC69367
0.8889 High Similarity NPC202391
0.8889 High Similarity NPC296659
0.8875 High Similarity NPC226759
0.8841 High Similarity NPC282551
0.8802 High Similarity NPC316539
0.8797 High Similarity NPC194705
0.8797 High Similarity NPC478235
0.8773 High Similarity NPC206815
0.8766 High Similarity NPC77922
0.8766 High Similarity NPC473281
0.8758 High Similarity NPC49173
0.8742 High Similarity NPC229354
0.8742 High Similarity NPC157898
0.8734 High Similarity NPC140151
0.8734 High Similarity NPC475379
0.8696 High Similarity NPC471405
0.8688 High Similarity NPC194095
0.8688 High Similarity NPC191046
0.8688 High Similarity NPC327032
0.8679 High Similarity NPC203664
0.8654 High Similarity NPC473867
0.865 High Similarity NPC208676
0.865 High Similarity NPC478265
0.865 High Similarity NPC130489
0.8645 High Similarity NPC184464
0.8645 High Similarity NPC251062
0.8642 High Similarity NPC4747
0.8642 High Similarity NPC472860
0.8642 High Similarity NPC133984
0.8642 High Similarity NPC104275
0.8639 High Similarity NPC171706
0.8636 High Similarity NPC296643
0.8634 High Similarity NPC172920
0.8634 High Similarity NPC10205
0.8634 High Similarity NPC156624
0.8631 High Similarity NPC470685
0.8625 High Similarity NPC257847
0.8616 High Similarity NPC478249
0.8616 High Similarity NPC269914
0.8608 High Similarity NPC92117
0.8606 High Similarity NPC100420
0.8599 High Similarity NPC473149
0.8589 High Similarity NPC469384
0.8581 High Similarity NPC478250
0.8581 High Similarity NPC186296
0.858 High Similarity NPC475299
0.8571 High Similarity NPC472128
0.8571 High Similarity NPC472127
0.8571 High Similarity NPC478232
0.8563 High Similarity NPC208818
0.8562 High Similarity NPC267091
0.8562 High Similarity NPC134905
0.8562 High Similarity NPC478268
0.8562 High Similarity NPC36130
0.8554 High Similarity NPC180586
0.8554 High Similarity NPC475738
0.8553 High Similarity NPC35097
0.8545 High Similarity NPC246024
0.8544 High Similarity NPC120728
0.8544 High Similarity NPC28776
0.8544 High Similarity NPC248257
0.8544 High Similarity NPC120621
0.8544 High Similarity NPC473138
0.8544 High Similarity NPC23677
0.8537 High Similarity NPC239966
0.8537 High Similarity NPC203020
0.8528 High Similarity NPC286919
0.8528 High Similarity NPC475663
0.8519 High Similarity NPC203757
0.8519 High Similarity NPC131532
0.8512 High Similarity NPC266545
0.8512 High Similarity NPC202428
0.8509 High Similarity NPC61152
0.8509 High Similarity NPC205037
0.8509 High Similarity NPC245615
0.8509 High Similarity NPC299706
0.8509 High Similarity NPC137813
0.8509 High Similarity NPC115466
0.8509 High Similarity NPC16024
0.8509 High Similarity NPC3746
0.8509 High Similarity NPC61604
0.8509 High Similarity NPC44260
0.8506 High Similarity NPC299855
0.8506 High Similarity NPC96194
0.85 High Similarity NPC243891
0.8497 Intermediate Similarity NPC302583
0.8497 Intermediate Similarity NPC84789
0.8497 Intermediate Similarity NPC310252
0.8497 Intermediate Similarity NPC473205
0.8497 Intermediate Similarity NPC100558
0.8497 Intermediate Similarity NPC473776
0.8491 Intermediate Similarity NPC161955
0.8491 Intermediate Similarity NPC111785
0.8488 Intermediate Similarity NPC198902
0.8481 Intermediate Similarity NPC18789
0.848 Intermediate Similarity NPC67629
0.848 Intermediate Similarity NPC79736
0.8476 Intermediate Similarity NPC160780
0.8476 Intermediate Similarity NPC289811
0.8466 Intermediate Similarity NPC475378
0.8466 Intermediate Similarity NPC478248
0.8462 Intermediate Similarity NPC293154
0.8457 Intermediate Similarity NPC189704
0.8452 Intermediate Similarity NPC476385
0.8452 Intermediate Similarity NPC298847
0.8452 Intermediate Similarity NPC7518
0.8452 Intermediate Similarity NPC134405
0.8452 Intermediate Similarity NPC177362
0.8452 Intermediate Similarity NPC154262
0.8452 Intermediate Similarity NPC159387
0.8452 Intermediate Similarity NPC47471
0.8452 Intermediate Similarity NPC137501
0.8452 Intermediate Similarity NPC476377
0.8447 Intermediate Similarity NPC106818
0.8442 Intermediate Similarity NPC89105
0.8442 Intermediate Similarity NPC81515
0.8442 Intermediate Similarity NPC64141
0.8442 Intermediate Similarity NPC68092
0.8442 Intermediate Similarity NPC476383
0.8442 Intermediate Similarity NPC472350
0.8442 Intermediate Similarity NPC197316
0.8439 Intermediate Similarity NPC188217
0.8438 Intermediate Similarity NPC147224
0.8434 Intermediate Similarity NPC14030
0.8434 Intermediate Similarity NPC33298
0.8434 Intermediate Similarity NPC148273
0.8434 Intermediate Similarity NPC285108
0.8434 Intermediate Similarity NPC291957
0.8431 Intermediate Similarity NPC471345
0.843 Intermediate Similarity NPC469418
0.843 Intermediate Similarity NPC260300
0.843 Intermediate Similarity NPC267549
0.843 Intermediate Similarity NPC80360
0.8428 Intermediate Similarity NPC308178
0.8424 Intermediate Similarity NPC289346
0.8421 Intermediate Similarity NPC469354
0.8415 Intermediate Similarity NPC172419
0.8415 Intermediate Similarity NPC1913
0.8415 Intermediate Similarity NPC238419
0.8409 Intermediate Similarity NPC475121
0.8409 Intermediate Similarity NPC476067
0.8408 Intermediate Similarity NPC300894
0.8408 Intermediate Similarity NPC296954
0.8408 Intermediate Similarity NPC141455
0.8408 Intermediate Similarity NPC196063
0.8405 Intermediate Similarity NPC38699
0.8402 Intermediate Similarity NPC658
0.8402 Intermediate Similarity NPC197708
0.8397 Intermediate Similarity NPC222433
0.8397 Intermediate Similarity NPC265648
0.8395 Intermediate Similarity NPC478241
0.8395 Intermediate Similarity NPC89693
0.8395 Intermediate Similarity NPC87403
0.8395 Intermediate Similarity NPC44730
0.8395 Intermediate Similarity NPC229548
0.8393 Intermediate Similarity NPC469458
0.8393 Intermediate Similarity NPC88176
0.8393 Intermediate Similarity NPC149002
0.8393 Intermediate Similarity NPC469419
0.8393 Intermediate Similarity NPC469396
0.8393 Intermediate Similarity NPC200726
0.8393 Intermediate Similarity NPC469459
0.8387 Intermediate Similarity NPC475530
0.8387 Intermediate Similarity NPC473799
0.8385 Intermediate Similarity NPC474620
0.8383 Intermediate Similarity NPC470898
0.8383 Intermediate Similarity NPC100425
0.8382 Intermediate Similarity NPC195114
0.8377 Intermediate Similarity NPC78363
0.8377 Intermediate Similarity NPC260425
0.8375 Intermediate Similarity NPC478242
0.8375 Intermediate Similarity NPC75945
0.8375 Intermediate Similarity NPC98809
0.8375 Intermediate Similarity NPC476394
0.8373 Intermediate Similarity NPC472859
0.8373 Intermediate Similarity NPC25389
0.8373 Intermediate Similarity NPC311803
0.8372 Intermediate Similarity NPC469397
0.8366 Intermediate Similarity NPC123988
0.8366 Intermediate Similarity NPC476870
0.8364 Intermediate Similarity NPC104222
0.8364 Intermediate Similarity NPC74319

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC145847 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9264 High Similarity NPD7685 Pre-registration
0.8442 Intermediate Similarity NPD7266 Discontinued
0.8276 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7054 Approved
0.814 Intermediate Similarity NPD7074 Phase 3
0.814 Intermediate Similarity NPD7472 Approved
0.8129 Intermediate Similarity NPD3818 Discontinued
0.8046 Intermediate Similarity NPD7251 Discontinued
0.8024 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD7808 Phase 3
0.8 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7989 Intermediate Similarity NPD6797 Phase 2
0.7976 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD7228 Approved
0.7901 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD6190 Approved
0.7836 Intermediate Similarity NPD7199 Phase 2
0.7771 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD6234 Discontinued
0.7716 Intermediate Similarity NPD4628 Phase 3
0.7684 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD230 Phase 1
0.7654 Intermediate Similarity NPD8313 Approved
0.7654 Intermediate Similarity NPD8312 Approved
0.765 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7637 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD37 Approved
0.7633 Intermediate Similarity NPD1934 Approved
0.763 Intermediate Similarity NPD8127 Discontinued
0.7619 Intermediate Similarity NPD4380 Phase 2
0.7602 Intermediate Similarity NPD4967 Phase 2
0.7602 Intermediate Similarity NPD4965 Approved
0.7602 Intermediate Similarity NPD4966 Approved
0.76 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD6166 Phase 2
0.76 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD8455 Phase 2
0.7588 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD5844 Phase 1
0.7542 Intermediate Similarity NPD6559 Discontinued
0.7514 Intermediate Similarity NPD7799 Discontinued
0.75 Intermediate Similarity NPD1653 Approved
0.75 Intermediate Similarity NPD8166 Discontinued
0.7485 Intermediate Similarity NPD6273 Approved
0.7485 Intermediate Similarity NPD1465 Phase 2
0.7457 Intermediate Similarity NPD7075 Discontinued
0.7456 Intermediate Similarity NPD7458 Discontinued
0.7444 Intermediate Similarity NPD7240 Approved
0.7442 Intermediate Similarity NPD3817 Phase 2
0.7384 Intermediate Similarity NPD7819 Suspended
0.7384 Intermediate Similarity NPD2801 Approved
0.736 Intermediate Similarity NPD7473 Discontinued
0.7337 Intermediate Similarity NPD8150 Discontinued
0.7321 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7028 Phase 2
0.7299 Intermediate Similarity NPD3882 Suspended
0.7288 Intermediate Similarity NPD6232 Discontinued
0.7283 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5494 Approved
0.7262 Intermediate Similarity NPD1511 Approved
0.725 Intermediate Similarity NPD3764 Approved
0.7241 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6801 Discontinued
0.7216 Intermediate Similarity NPD8320 Phase 1
0.7216 Intermediate Similarity NPD8319 Approved
0.7215 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7236 Approved
0.719 Intermediate Similarity NPD9545 Approved
0.7178 Intermediate Similarity NPD6653 Approved
0.7176 Intermediate Similarity NPD1512 Approved
0.7165 Intermediate Similarity NPD7680 Approved
0.7165 Intermediate Similarity NPD7435 Discontinued
0.7157 Intermediate Similarity NPD8151 Discontinued
0.7151 Intermediate Similarity NPD8434 Phase 2
0.7151 Intermediate Similarity NPD3455 Phase 2
0.715 Intermediate Similarity NPD7930 Approved
0.7143 Intermediate Similarity NPD5402 Approved
0.7135 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6355 Discontinued
0.7099 Intermediate Similarity NPD6663 Approved
0.7093 Intermediate Similarity NPD7239 Suspended
0.7092 Intermediate Similarity NPD7999 Approved
0.7083 Intermediate Similarity NPD3750 Approved
0.7083 Intermediate Similarity NPD7699 Phase 2
0.7083 Intermediate Similarity NPD7700 Phase 2
0.7081 Intermediate Similarity NPD3027 Phase 3
0.7069 Intermediate Similarity NPD6385 Approved
0.7069 Intermediate Similarity NPD6386 Approved
0.7069 Intermediate Similarity NPD7411 Suspended
0.7066 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD9494 Approved
0.7063 Intermediate Similarity NPD5736 Approved
0.7055 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD2935 Discontinued
0.7035 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD7874 Approved
0.7035 Intermediate Similarity NPD5403 Approved
0.7024 Intermediate Similarity NPD6674 Discontinued
0.7017 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD6535 Approved
0.7016 Intermediate Similarity NPD6534 Approved
0.701 Intermediate Similarity NPD6780 Approved
0.701 Intermediate Similarity NPD6782 Approved
0.701 Intermediate Similarity NPD6781 Approved
0.701 Intermediate Similarity NPD6777 Approved
0.701 Intermediate Similarity NPD6779 Approved
0.701 Intermediate Similarity NPD6776 Approved
0.701 Intermediate Similarity NPD6778 Approved
0.7006 Intermediate Similarity NPD5763 Approved
0.7006 Intermediate Similarity NPD5762 Approved
0.7006 Intermediate Similarity NPD7768 Phase 2
0.7 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7783 Phase 2
0.6995 Remote Similarity NPD8470 Clinical (unspecified phase)
0.699 Remote Similarity NPD7497 Discontinued
0.699 Remote Similarity NPD7697 Approved
0.699 Remote Similarity NPD7698 Approved
0.699 Remote Similarity NPD7696 Phase 3
0.6988 Remote Similarity NPD1510 Phase 2
0.6988 Remote Similarity NPD7033 Discontinued
0.6982 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6982 Remote Similarity NPD4110 Phase 3
0.6964 Remote Similarity NPD1549 Phase 2
0.6962 Remote Similarity NPD9269 Phase 2
0.6962 Remote Similarity NPD1608 Approved
0.6959 Remote Similarity NPD6799 Approved
0.6954 Remote Similarity NPD7871 Phase 2
0.6954 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6954 Remote Similarity NPD7870 Phase 2
0.6952 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6951 Remote Similarity NPD3620 Phase 2
0.6951 Remote Similarity NPD1613 Approved
0.6951 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6951 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6951 Remote Similarity NPD943 Approved
0.6949 Remote Similarity NPD5353 Approved
0.694 Remote Similarity NPD3751 Discontinued
0.6935 Remote Similarity NPD7585 Approved
0.6935 Remote Similarity NPD7701 Phase 2
0.6919 Remote Similarity NPD5401 Approved
0.6919 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6919 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6918 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6915 Remote Similarity NPD7801 Approved
0.6914 Remote Similarity NPD6599 Discontinued
0.6909 Remote Similarity NPD1933 Approved
0.6905 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6905 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6905 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6905 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6905 Remote Similarity NPD6004 Phase 3
0.6905 Remote Similarity NPD6005 Phase 3
0.6905 Remote Similarity NPD6002 Phase 3
0.6893 Remote Similarity NPD5760 Phase 2
0.6893 Remote Similarity NPD5761 Phase 2
0.6884 Remote Similarity NPD7583 Approved
0.6882 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6213 Phase 3
0.6875 Remote Similarity NPD6212 Phase 3
0.6875 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6871 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6868 Remote Similarity NPD5242 Approved
0.6853 Remote Similarity NPD6823 Phase 2
0.6852 Remote Similarity NPD2861 Phase 2
0.6851 Remote Similarity NPD6959 Discontinued
0.6845 Remote Similarity NPD2796 Approved
0.6829 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6826 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6826 Remote Similarity NPD7097 Phase 1
0.6821 Remote Similarity NPD2533 Approved
0.6821 Remote Similarity NPD2534 Approved
0.6821 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6821 Remote Similarity NPD2532 Approved
0.6821 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6813 Remote Similarity NPD3787 Discontinued
0.68 Remote Similarity NPD7584 Approved
0.6791 Remote Similarity NPD7039 Approved
0.6791 Remote Similarity NPD6764 Approved
0.6791 Remote Similarity NPD7038 Approved
0.6791 Remote Similarity NPD6765 Approved
0.679 Remote Similarity NPD2798 Approved
0.679 Remote Similarity NPD5647 Approved
0.6788 Remote Similarity NPD6233 Phase 2
0.6786 Remote Similarity NPD3748 Approved
0.6784 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6778 Remote Similarity NPD3749 Approved
0.6772 Remote Similarity NPD17 Approved
0.677 Remote Similarity NPD1876 Approved
0.6761 Remote Similarity NPD3226 Approved
0.676 Remote Similarity NPD5977 Approved
0.676 Remote Similarity NPD5978 Approved
0.6747 Remote Similarity NPD1240 Approved
0.6747 Remote Similarity NPD4140 Approved
0.6746 Remote Similarity NPD2438 Suspended
0.674 Remote Similarity NPD919 Approved
0.6728 Remote Similarity NPD3094 Phase 2
0.6728 Remote Similarity NPD2797 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data